Case Control Study
Copyright ©The Author(s) 2017.
World J Hepatol. Jan 18, 2017; 9(2): 91-98
Published online Jan 18, 2017. doi: 10.4254/wjh.v9.i2.91
Table 1 Clinical characteristics of the study population
Variablen1Mean ± SD
Age (yr)7742.4 ± 12.98
Gender (male) %7746.8
BMI (kg/m2)7741.71 ± 4.68
Glucose (mg/dL) (< 100)48116.81 ± 35.08
Total cholesterol (mg/dL) (< 200)42191.97 ± 34.46
LDL (mg/dL)42112.80 ± 33.05
HDL (mg/dL)4044.19 ± 11.87
TG (mg/dL) (< 150)42182.38 ± 56.36
ALT (U/L) (5-39)4744.28 ± 44.49
AST (U/L) (7-40)4728.91 ± 20.11
Success rate %7784.31 ± 13.55
Stiffness7710.24 ± 6.27
Sedentary time2 (min/d)77263.84 ± 176.56
Daily activity (score3)7720.56 ± 3.47
Alcohol servings/week770.66 ± 1.67
Current or past smokers %7748.1
Table 2 Comparison between subjects with fibrosis degree F < 2 and subjects with significant fibrosis degree F ≥ 2 (mean ± SD, unless otherwise stated)
VariableF < 2 (n = 31)F ≥ 2 (n = 46)P
Gender (men) %22.663< 0.001
Age (yr)42.32 ± 13.8942.96 ± 12.290.838
Education (yr)13.13 ± 2.0513.78 ± 2.90.281
BMI (kg/m2)39.82 ± 3.1642.99 ± 5.11< 0.001
Type 2 diabetes drugs (%)19.417.40.827
All sugared soft drinks (cups/d)1.76 ± 2.741.38 ± 2.240.502
Carbonated sugared drinks intake (cups/d)0.99 ± 1.520.89 ± 1.980.816
Diet carbonated drinks intake (cups/d)0.46 ± 0.980.88 ± 1.60.196
Coffee intake (cups/d)2.22 ± 1.871.77 ± 1.740.287
Alcohol servings/week0.97 ± 1.800.46 ± 1.560.189
Current or past smokers (%)48.447.80.961
Fruits intake (portions/d)1.71 ± 1.351.74 ± 1.310.924
Vegetables intake (portions/d)2.77 ± 2.382.64 ± 1.930.788
Fried food intake (portions/d)1.18 ± 1.251.08 ± 0.770.690
Leisure time physical activity (min/wk)189 ± 83.06237.69 ± 437.890.733
Sedentary time1 (min/d)264.19 ± 171.7263.61 ± 181.650.989
Daily activity (score2)20.19 ± 2.8320.8 ± 3.850.452
Glucose (mg/dL)113.72 ± 42.35119.42 ± 28.130.580
Total cholesterol (mg/dL)202.68 ± 37.79182.24 ± 28.60.054
LDL (mg/dL)121.52 ± 38.77104.04 ± 23.970.088
HDL (mg/dL)46.55 ± 11.4241.83 ± 12.130.213
Triglycerides (mg/dL)170.73 ± 60.25192 ± 52.30.228
ALT (U/L)34.89 ± 37.7750.66 ± 48.130.237
AST (U/L)26.4 ± 24.4730.78 ± 16.430.467
GGT (U/L)22.52 ± 12.0143.06 ± 23.530.090
Table 3 Comparison between subjects with fibrosis degree F < 3 and subjects with advanced fibrosis degree F ≥ 3 (mean ± SD, unless otherwise stated)
VariableF < 3 (n = 47)F ≥ 3 (n = 30)P
Gender (male) %36.263.30.020
Age (yr)42.47 ± 1443.07 ± 11.090.836
Education (yr)13.19 ± 2.5914.03 ± 2.550.166
BMI (kg/m2)40.68 ± 3.9642.32 ± 5.30.023
Type 2 diabetes drugs (%)17200.741
All sugared soft drinks (cups/d)1.64 ± 2.451.37 ± 2.460.635
Carbonated sugared drinks intake (cups/d)0.9 ± 1.550.98 ± 2.160.850
Diet carbonated drinks intake (cups/d)0.73 ± 1.440.68 ± 1.330.890
Coffee intake (cups/d)1.96 ± 1.881.93 ± 1.690.951
Alcohol (servings/wk)0.87 ± 1.760.33 ± 1.470.152
Current or past smokers (%)48.946.70.846
Fruits intake (portions/d)1.57 ± 1.251.97 ± 1.40.204
Vegetables intake (portions/d)2.43 ± 2.113.12 ± 2.070.162
Fried food intake (portions/d)1.12 ± 1.121.12 ± 0.750.999
Leisure time physical activity (min/wk)155.62 ± 89.96355.71 ± 585.970.403
Sedentary time1 (min/d)265.66 ± 178.79261.00 ± 176.010.911
Daily activity (score2)20.32 ± 3.4920.93 ± 3.450.452
Glucose (mg/dL)117 ± 39.93116.53 ± 27.080.964
Total cholesterol (mg/dL)197.75 ± 37.39180.41 ± 250.083
LDL (mg/dL)117.81 ± 35.94101.61 ± 22.000.087
HDL (mg/dL)44.85 ± 11.1642.82 ± 13.60.619
Triglycerides (mg/dL)176.28 ± 55.14194.57 ± 58.840.328
ALT (U/L)36.5 ± 33.2655.76 ± 56.260.147
AST (U/L)26.89 ± 21.9931.89 ± 17.110.409
GGT (U/L)29.89 ± 26.2543.4 ± 16.960.241
Table 4 Multivariate analysis for the prediction of significant or advanced fibrosis
VariableModel 1: F ≥ 2
Model 2: F ≥ 3
OR (95%CI)POR (95%CI)P
Age (yr)1.03 (0.99-1.08)0.1531.03 (0.98-1.07)0.246
Gender (male)7.93 (2.36-26.64)0.0012.92 (1.08-7.91)0.035
BMI (kg/m2)1.33 (1.11-1.60)0.0021.17 (1.03-1.33)0.018